as on October 21, 2025 at 10:40 pm IST
Day's Low
Day's High
2.04%
Downside
2.04%
Upside
52 Week's Low
52 Week's High
48.98%
Downside
644.88%
Upside
Check Moleculin Biotech, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$25.2M
EPS (TTM)
-5.28
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-25.3M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
389900.00%
Compare market cap, revenue, PE, and other key metrics of Moleculin Biotech, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $25.2M | -99.27% | NA | 0.00% | |
BUY | $35.5B | 359.02% | -16.34 | -259.82% | |
BUY | $63.1B | 259.92% | -505.15 | -12.96% | |
BUY | $106.9B | 98.27% | 29.67 | 31.86% | |
BUY | $61.3B | 0.76% | 14.58 | 31.37% |
The Moleculin Biotech, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moleculin Biotech, Inc. investment value today
Current value as on today
₹23,160
Returns
Returns from Moleculin Biotech, Inc. Stock
Dollar Returns*
₹4,808 (+4.81%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Moleculin Biotech, Inc.. Average target price of $6.67
Get share price movements and forecasts by analysts on Moleculin Biotech, Inc..
What analysts predicted
92.65%UPSIDE
Target Price
$6.67
Current Price
$0.49
Analyzed by
9 Analysts
Target
$6.67
Moleculin Biotech, Inc. target price $6.67, a slight upside of 92.65% compared to current price of $0.49. According to 9 analysts rating.
Search interest for Moleculin Biotech, Inc. Stock has increased by 21% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:21% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 September
Mon, 06:06 AM
-Moleculin Biotech's Performance-based Restricted Stock Units under lock-up agreement ending on 22-SEP-2025, restricting stock sales.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, MBRX stock has moved up by 25.3%
Against Peers
In the last 1 year, Insmed Incorporated has given 132.3% return, outperforming this stock by 213.4%
Against Peers
In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 906.0%
Organisation | Moleculin Biotech, Inc. |
Headquarters | 5300 Memorial Drive, Houston, TX, United States, 77007 |
Industry | Health Technology |
CEO | Mr. Walter V. Klemp |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Walter V. Klemp | Co-Founder, Chairman, President & CEO |
Mr. Jonathan P. Foster CPA | Executive VP & CFO |
Dr. Donald H. Picker Ph.D. | Chief Scientific Officer |
Dr. Waldemar Priebe Ph.D. | Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board |
Dr. John Paul Waymack M.D., Sc.D. | Senior Chief Medical Officer |
Moleculin Biotech, Inc. share price today is $0.49 as on . Moleculin Biotech, Inc. share today touched a day high of $0.5 and a low of $0.48.
Moleculin Biotech, Inc. share touched a 52 week high of $3.65 on and a 52 week low of $0.25 on . Moleculin Biotech, Inc. stock price today i.e. is trending at $0.49,which is 86.57% down from its 52 week high and 96.00% up from its 52 week low.
Moleculin Biotech, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Moleculin Biotech, Inc. (MBRX) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Moleculin Biotech, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moleculin Biotech, Inc. share’s latest price of $0.49 as on October 21, 2025 at 10:40 pm IST, you will get 20.4082 shares of Moleculin Biotech, Inc.. Learn more about
fractional shares .
Moleculin Biotech, Inc. stock has given -99.27% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?